Masayuki Nakamori

9PUBLICATIONS
20CO-AUTHORS
Neurology and neuromuscular diseasesMedical molecular engineering of nucleic acids and proteinsMedical mycologyRheumatology and arthritisEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 28, 2026
U1 Small Nuclear Ribonucleoprotein Autoantibodies Reflect the Disruption of the Blood-Nerve Barrier in Guillain-Barré Syndrome.

|Feb 19, 2026
Identification of enzymatically modified isoquercitrin as a therapeutic lead for myotonic dystrophy type 1.

Subodh K Mishra, Sawyer M Hicks, Jesus A Frias

|Jan 28, 2026
Blood-Nerve Barrier Breakdown Induced by Immunoglobulin G in Typical and Multifocal Chronic Inflammatory Demyelinating Polyneuropathy and Multifocal Motor Neuropathy.

Fumitaka Shimizu, Ryota Sato, Yoichi Mizukami

|Jul 02, 2025
Molecular genetics of myotonic dystrophy and the evolution of therapeutic approaches.

Joe Nemoto, Masayuki Nakamori

|May 19, 2025
Small Nuclear Ribonucleoprotein Autoantibody Associated With Blood-Nerve Barrier Breakdown in Guillain-Barré Syndrome.

Fumitaka Shimizu, Michiaki Koga, Yoichi Mizukami

|Apr 16, 2025
Pentatricopeptide repeat protein targeting CUG repeat RNA ameliorates RNA toxicity in a myotonic dystrophy type 1 mouse model.

Takayoshi Imai, Maiko Miyai, Joe Nemoto

Pageof 2

Frequent Collaborators

4 joint publications

Fumitaka Shimizu

2 joint publications

Michiaki Koga

2 joint publications

Joe Nemoto

2 joint publications

Kenji Watanabe